Literature DB >> 17229189

Analysis of adverse drug reactions for preventability.

M M Ducharme1, L A Boothby.   

Abstract

Although preventability criteria have been assessed for all adverse drug reactions (ADRs) investigated at our institution over the past 12 years, a systematic evaluation of the data had not been performed. This project analysed preventability data previously collected to identify the potential areas for process improvements. A 3-year retrospective analysis was performed. All ADRs were categorised by drug, drug class, severity, probability of causality and preventability. Factors involved in preventability were assessed and tallied. Descriptive statistics was used to analyse the data. Most ADRs occurred prior to admission. In the outpatient setting, anticoagulants and anticonvulsants were associated with more preventable ADRs (pADRs) than other drug classes, followed by cardiotonic agents and non-steroidal anti-inflammatory drugs (NSAIDs). For ADRs that occurred in hospitalised patients, antibiotics and opiates were associated with approximately half of all pADRs. The preventability categories most frequently associated with ADRs prior to admission were presence of a toxic drug level and drug-drug interactions, while inappropriate dose, route or frequency was the most common preventability category for inpatient ADRs. The majority of pADRs were moderate in severity in both the in- and outpatient settings. Drugs and drug classes involved in pADRs differ in the in- and outpatient settings. Preventability categories also differ by setting. Most pADRs occur prior to admission in our healthcare system. This presents a challenge in terms of implementing the process changes to reduce the pADRs, as patients in the community are outside our control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229189     DOI: 10.1111/j.1742-1241.2006.01130.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  11 in total

1.  A prospective analysis of the preventability of adverse drug reactions reported in Sweden.

Authors:  Henrik Lövborg; Linda Ring Eriksson; Anna K Jönsson; Thomas Bradley; Staffan Hägg
Journal:  Eur J Clin Pharmacol       Date:  2012-02-19       Impact factor: 2.953

Review 2.  Preventability of drug-related harms - part I: a systematic review.

Authors:  Robin E Ferner; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

3.  Preventability analysis of adverse drug reactions detected in two internal medicine departments in Romania.

Authors:  Andreea Farcas; Camelia Bucsa; Aura Sinpetrean; Daniel Leucuta; Cristina Mogosan; Dan Dumitrascu; Andrei Cadariu Achimas; Marius Bojita
Journal:  Intern Emerg Med       Date:  2012-08-21       Impact factor: 3.397

4.  A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in England.

Authors:  Kinan Mokbel; Rob Daniels; Michael N Weedon; Leigh Jackson
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

5.  Systematic review of predictive risk models for adverse drug events in hospitalized patients.

Authors:  Nazanin Falconer; Michael Barras; Neil Cottrell
Journal:  Br J Clin Pharmacol       Date:  2018-02-22       Impact factor: 4.335

6.  Methods for evaluating adverse drug event preventability in emergency department patients.

Authors:  Stephanie A Woo; Amber Cragg; Maeve E Wickham; David Peddie; Ellen Balka; Frank Scheuermeyer; Diane Villanyi; Corinne M Hohl
Journal:  BMC Med Res Methodol       Date:  2018-12-04       Impact factor: 4.615

7.  Improving drug safety in hospitals: a retrospective study on the potential of adverse drug events coded in routine data.

Authors:  Nils Kuklik; Jürgen Stausberg; Marjan Amiri; Karl-Heinz Jöckel
Journal:  BMC Health Serv Res       Date:  2019-08-08       Impact factor: 2.655

8.  Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes.

Authors:  Emma C Davies; Christopher F Green; Stephen Taylor; Paula R Williamson; David R Mottram; Munir Pirmohamed
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240

9.  Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residents.

Authors:  Shadi Baniasadi; Maryam Habibi; Roodabeh Haghgoo; Masoumeh Karimi Gamishan; Fatemeh Dabaghzadeh; Maryam Farasatinasab; Shadi Farsaei; Afshin Gharekhani; Hamidreza Kafi; Iman Karimzadeh; Ali Kharazmkia; Farhad Najmeddin; Naemeh Nikvarz; Mohammad Bagher Oghazian; Haleh Rezaee; Kourosh Sadeghi; Ali Tafazzoli; Nahid Shahsavari; Fanak Fahimi
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

Review 10.  Patient harm from cardiovascular medications.

Authors:  Chariclia Paradissis; Neil Cottrell; Ian Coombes; Ian Scott; William Wang; Michael Barras
Journal:  Ther Adv Drug Saf       Date:  2021-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.